For a summary of the published research, Rupa Healths clinical review of BPC-157 covers the available data
CVS CAREMARK CRITERIA Formulary Exception Requirements Since Zepbound is excluded from CVS Caremark formularies, you'll need to request a formulary exception
Anyone considering a compounded GLP-1 program should discuss the current legal status of these medications with a licensed clinician before enrolling - not after
The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
Mar 2011;34(3):610-615
Kevin Borg, PharmD: Yeah, and thats a great opportunity for, you know, normally the pharmacies that are just doing retail and dont do any compounding